調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023

治療薬モニタリングの世界市場予測（～2023年）

◆タイトル：Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023
◆商品コード：MD-4185
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年8月22日
◆ページ数：142
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥920,950見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、治療薬モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（消耗品、装置）分析、技術別（蛍光免疫測定、放射免疫測定法、GCMS）分析、薬剤クラス別（抗生物質、気管支拡張剤）分析、エンドユーザー別（病院内ラボ）分析、治療薬モニタリングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global therapeutic drug monitoring (TDM) market is projected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.
In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.

On the basis of end user, the therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. Hospital laboratories is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays.

In 2018, North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region.

However, the lack of financial provisions for the clinical interpretation of TDM results is expected to restrain the growth of this market during the forecast period.

The key players operating in the TDM market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US). A majority of leading players in the TDM market focus on both organic and inorganic growth strategies to maintain and enhance their market share in the TDM market.

【レポートの目次】

Table of Contents

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data Sources From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.2.1 Key Industry Insights

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Therapeutic Drug Monitoring (TDM): Market Overview
4.2 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug
4.3 Geographic Mix: Therapeutic Drug Monitoring Market
4.4 Therapeutic Drug Monitoring Market, By End User

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Use of TDM in Traditional Anticancer Therapies
5.2.1.2 Rising Number of Organ Transplant Procedures
5.2.2 Restraints
5.2.2.1 Reluctance of Small Hospitals to Offer TDM Services
5.2.3 Opportunities
5.2.3.1 Monitoring of Biosimilars in Autoimmune Diseases
5.2.4 Challenges
5.2.4.1 Operational Barriers Faced in Conducting TDM Tests

6 Therapeutic Drug Monitoring Market, By Product (Page No. – 34)
6.1 Introduction
6.2 Consumables
6.3 Equipment
6.3.1 Immunoassay Analyzers
6.3.2 Chromatography and MS Detectors
6.3.3 Clinical Chemistry Analyzers

7 Therapeutic Drug Monitoring Market, By Technology (Page No. – 42)
7.1 Introduction
7.2 Immunoassays
7.2.1 Chemiluminescent Immunoassays
7.2.2 Fluorescence Immunoassays
7.3 Colorimetric Immunoassays
7.4 Radioimmunoassays
7.5 Other Immunoassays
7.6 Chromatography-MS
7.6.1 Liquid Chromatography/Mass Spectrometry (LC-MS)
7.6.2 Gas Chromatography-Mass Spectrometry

8 Therapeutic Drug Monitoring Market, By Class of Drug (Page No. – 58)
8.1 Introduction
8.2 Antiepileptic Drugs
8.3 Antiarrhythmic Drugs
8.4 Immunosuppressant Drugs
8.5 Antibiotic Drugs
8.6 Bronchodilator Drugs
8.7 Psychoactive Drugs
8.8 Other Drug Classes

9 Therapeutic Drug Monitoring Market, By End User (Page No. – 70)
9.1 Introduction
9.2 Hospital Laboratories
9.3 Commercial/Private Laboratories
9.4 Other End Users

10 Therapeutic Drug Monitoring Market, By Region (Page No. – 77)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoAPAC
10.5 Rest of the World

11 Competitive Landscape (Page No. – 112)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Mergers & Acquisitions

12 Company Profiles (Page No. – 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Abbott Laboratories
12.2 F. Hoffmann-La Roche
12.3 Siemens Healthineers
12.4 Thermo Fisher Scientific
12.5 Danaher Corporation
12.6 Bio-Rad Laboratories
12.7 Biomérieux
12.8 Bühlmann Laboratories
12.9 Sekisui Medical
12.10 Randox Laboratories

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 135)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (145 Tables)

Table 1 Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 2 Therapeutic Drug Monitoring Consumables Market, By Region, 2016–2023 (USD Million)
Table 3 North America: Therapeutic Drug Monitoring Consumables Market, By Country, 2016–2023 (USD Million)
Table 4 Asia Pacific: Therapeutic Drug Monitoring Consumables Market, By Country, 2016–2023 (USD Million)
Table 5 Therapeutic Drug Monitoring Equipment Market, By Region, 2016–2023 (USD Million)
Table 6 North America: Therapeutic Drug Monitoring Equipment Market, By Country, 2016–2023 (USD Million)
Table 7 Asia Pacific: Therapeutic Drug Monitoring Equipment Market, By Country, 2016–2023 (USD Million)
Table 8 Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million)
Table 9 Therapeutic Drug Monitoring Market for Immunoassay Analyzers, By Region, 2016–2023 (USD Million)
Table 10 Therapeutic Drug Monitoring Market for Chromatography and MS Detectors, By Region, 2016–2023 (USD Million)
Table 11 Therapeutic Drug Monitoring Market for Clinical Chemistry Analyzers, By Region, 2016–2023 (USD Million)
Table 12 Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 13 Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 14 Therapeutic Drug Monitoring Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 15 North America: Therapeutic Drug Monitoring Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 16 Asia Pacific: Therapeutic Drug Monitoring Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 17 Clia Systems Available in the Market
Table 18 Chemiluminescent Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 19 North America: Chemiluminescent Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 20 Asia Pacific: Chemiluminescent Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 21 Fluorescence Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 22 North America: Fluorescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 23 Asia Pacific: Fluorescence Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 24 Colorimetric Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 25 North America: Colorimetric Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 26 Asia Pacific: Colorimetric Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 27 Radioimmunoassays Market, By Region, 2016–2023 (USD Million)
Table 28 North America: Radioimmunoassays Market, By Country, 2016–2023 (USD Million)
Table 29 Asia Pacific: Radioimmunoassays Market, By Country, 2016–2023 (USD Million)
Table 30 Other Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 31 North America: Other Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 32 Asia Pacific: Other Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 33 Therapeutic Drug Monitoring Chromatography-MS Market, By Type, 2016–2023 (USD Million)
Table 34 Therapeutic Drug Monitoring Chromatography-MS Market, By Region, 2016–2023 (USD Million)
Table 35 North America: Therapeutic Drug Monitoring Chromatography-MS Market, By Country, 2016–2023 (USD Million)
Table 36 Asia Pacific: Therapeutic Drug Monitoring Chromatography-MS, By Country, 2016–2023 (USD Million)
Table 37 Liquid Chromatography-Mass Spectrometry Market, By Region, 2016–2023 (USD Million)
Table 38 North America: Liquid Chromatography-Mass Spectrometry Market, By Country, 2016–2023 (USD Million)
Table 39 Asia Pacific: Liquid Chromatography-Mass Spectrometry Market, By Country, 2016–2023 (USD Million)
Table 40 Gas Chromatography-Mass Spectrometry Market, By Region, 2016–2023 (USD Million)
Table 41 North America: Gas Chromatography-Mass Spectrometry Market, By Country, 2016–2023 (USD Million)
Table 42 Asia Pacific: Gc-MS Market, By Country, 2016–2023 (USD Million)
Table 43 Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 44 Guidelines for the Monitoring of Antiepileptic Drugs
Table 45 Antiepileptic Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 46 North America: Antiepileptic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 47 Asia Pacific: Antiepileptic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 48 Antiarrhythmic Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 49 North America: Antiarrhythmic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 50 Asia Pacific: Antiarrhythmic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 51 Immunosuppressant Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 52 North America: Immunosuppressant Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 53 Asia Pacific: Immunosuppressant Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 54 Antibiotic Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 55 North America: Antibiotic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 56 Asia Pacific: Antibiotic Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 57 Therapeutic Ranges for Bronchodilators
Table 58 Bronchodilator Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 59 North America: Bronchodilator Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 60 Asia Pacific: Bronchodilator Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 61 Psychoactive Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 62 North America: Psychoactive Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 63 Asia Pacific: Psychoactive Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 64 Other Drugs Monitoring Market, By Region, 2016–2023 (USD Million)
Table 65 North America: Other Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 66 Asia Pacific: Other Drugs Monitoring Market, By Country, 2016–2023 (USD Million)
Table 67 Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 68 Therapeutic Drug Monitoring Market for Hospital Laboratories, By Region, 2016-2023 (USD Million)
Table 69 North America: Therapeutic Drug Monitoring for Hospital Laboratories, By Country, 2016–2023 (USD Million)
Table 70 Asia Pacific: Therapeutic Drug Monitoring for Hospital Laboratories, By Country, 2016–2023 (USD Million)
Table 71 Therapeutic Drug Monitoring Market for Commercial/Private Laboratories, By Region, 2013-2023 (USD Million)
Table 72 North America: Therapeutic Drug Monitoring for Commercial/ Private Laboratories, By Country, 2016–2023 (USD Million)
Table 73 Asia Pacific: Therapeutic Drug Monitoring for Commercial/ Private Laboratories, By Country, 2016–2023 (USD Million)
Table 74 Therapeutic Drug Monitoring Market for Other End Users, By Region, 2016-2023 (USD Million)
Table 75 North America: Therapeutic Drug Monitoring for Other End Users, By Country, 2016–2023 (USD Million)
Table 76 Asia Pacific: Therapeutic Drug Monitoring for Other End Users, By Country, 2016–2023 (USD Million)
Table 77 Therapeutic Drug Monitoring Market, By Region, 2016–2023 (USD Million)
Table 78 North America: Therapeutic Drug Monitoring Market, By Country, 2016–2023 (USD Million)
Table 79 North America: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 80 North America: Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million)
Table 81 North America: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 82 North America: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 83 North America: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 84 North America: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 85 North America: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 86 US: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 87 US: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 88 US: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 89 US: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 90 US: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 91 US: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 92 Canada: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 93 Canada: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 94 Canada: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 95 Canada: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 96 Canada: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 97 Canada: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 98 Europe: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 99 Europe: Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million)
Table 100 Europe: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 101 Europe: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 102 Europe: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 103 Europe: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 104 Europe: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 105 Asia Pacific: Therapeutic Drug Monitoring Market, By Country, 2016–2023 (USD Million)
Table 106 Asia Pacific: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 107 Asia Pacific: Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million)
Table 108 Asia Pacific: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 109 Asia Pacific: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 110 Asia Pacific: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 111 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 112 Asia Pacific: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 113 Japan: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 114 Japan: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 115 Japan: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 116 Japan: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 117 Japan: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 118 Japan: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 119 China: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 120 China: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 121 China: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 122 China: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 123 China: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 124 China: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 125 India: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 126 India: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 127 India: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 128 India: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 129 India: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 130 India: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 131 RoAPAC: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 132 RoAPAC: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 133 RoAPAC: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 134 RoAPAC: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 135 RoAPAC: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 136 RoAPAC: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 137 RoW: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million)
Table 138 RoW: Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million)
Table 139 RoW: Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million)
Table 140 RoW: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)
Table 141 RoW: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 2016–2023 (USD Million)
Table 142 RoW: Therapeutic Drug Monitoring Market, By Class of Drug, 2016–2023 (USD Million)
Table 143 RoW: Therapeutic Drug Monitoring Market, By End User, 2016–2023 (USD Million)
Table 144 Product Launches/Approvals, 2015–2018
Table 145 Mergers & Acquisitions, 2015–2018

List of Figures (23 Figures)

Figure 1 Research Design
Figure 2 Therapeutic Drug Monitoring Market: Top-Down Approach
Figure 3 Therapeutic Drug Monitoring Market: Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Method
Figure 6 Therapeutic Drug Monitoring Market, By Product, 2018 vs 2023 (USD Billion)
Figure 7 Therapeutic Drug Monitoring Market, By Class of Drug, 2018 vs 2023 (USD Million)
Figure 8 Therapeutic Drug Monitoring Market, By Technology, 2018 vs 2023 (USD Million)
Figure 9 Geographic Snapshot of the Therapeutic Drug Monitoring Market
Figure 10 Growth of This Market is Majorly Driven By the Rising Number of Organ Transplant Procedures
Figure 11 Antiepileptic Drugs Will Dominate the Asia Pacific TDM Class of Drugs Market in 2018
Figure 12 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 13 Therapeutic Drug Monitoring Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 North America: Therapeutic Drug Monitoring Market Snapshot
Figure 15 Asia Pacific: Therapeutic Drug Monitoring Market Snapshot
Figure 16 Therapeutic Drug Monitoring Market Ranking Analysis, By Key Player, 2017
Figure 17 Abbott Laboratories: Company Snapshot (2017)
Figure 18 Roche Diagnostics: Company Snapshot (2017)
Figure 19 Siemens Healthineers: Company Snapshot (2017)
Figure 20 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 21 Danaher Corporation: Company Snapshot (2017)
Figure 22 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 23 Biomérieux: Company Snapshot (2017)

★調査レポート[治療薬モニタリングの世界市場予測（～2023年）] ( Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023 / MD-4185) 販売に関する免責事項
[治療薬モニタリングの世界市場予測（～2023年）] ( Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023 / MD-4185) についてEメールでお問い合わせ
◆関連調査資料◆
  • イムノアッセイ（免疫学的検定）の世界市場予測（～2023年）：試薬・キット、分析装置、ソフトウェア
    MD4751 / MarketsandMarkets / 2018年5月14日 / MarketsandMarketsが発行した当調査レポートでは、イムノアッセイ（免疫学的検定）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス（試薬・キット、分析装置、ソフトウェア）別分析、技術別分析、プラットフォーム別分析、用途別分析、イムノアッセイ（免疫学的検定）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. The global immunoassays market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share...
  • In Vitro診断（IVD）の世界市場予測（～2023年）：IVD装置、IVD試薬
    MAM-MD-3609 / MarketsandMarkets / 2018年3月27日 / MarketsandMarketsが発行した当調査レポートでは、In Vitro診断（IVD）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、In Vitro診断（IVD）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion...
  • 分取・プロセスクロマトグラフィーの世界市場予測（～2023年）
    MAM-AST-3797 / MarketsandMarkets / 2018年10月3日 / MarketsandMarketsが発行した当調査レポートでは、分取・プロセスクロマトグラフィーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、タイプ別（分取、プロセス）分析、エンドユーザー別（バイオテクノロジー、医薬品）分析、分取・プロセスクロマトグラフィーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global process and preparative chromatography market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR of 6.5%. The major factors driving the growth of this market are increasing R&D investments in biotechnology and pharmaceutical industries and rising demand for monoclonal antibodies, insulin, and other pharmaceutical products. On the basis of type, the process and preparative chromatography market has been segmented into two segments, namely, process chromatography and preparative chromatography. Each segment has been further divided based on products and service. In 2018, the process chromatography segment is...
  • 高薬理活性原薬（HPAPI）の世界市場予測（～2023年）：種類、合成、メーカー、治療分野
    MAM-PH-4897 / MarketsandMarkets / 2018年4月18日 / MarketsandMarketsが発行した当調査レポートでは、高薬理活性原薬（HPAPI）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、合成別分析、メーカー別分析、治療分野別分析、高薬理活性原薬（HPAPI）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 17.72 Billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This report segments the HPAPIs market into type, type of manufacturer, type of synthesis, therapeutic application, and region. Based on type, the HPAPI market is segmented into innovative and generic APIs. In 2018, the innovative HPAPIs segment...
  • 二次元クロマトグラフィーの世界市場予測（～2023年）：2Dガスクロマトグラフィー、2D液体クロマトグラフィー
    AST-6614 / MarketsandMarkets / 2018年9月18日 / MarketsandMarketsが発行した当調査レポートでは、二次元クロマトグラフィーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（二次元ガスクロマトグラフィー、二次元液体クロマトグラフィー）分析、用途（生命科学研究、環境分析、食品・飲料検査、石油化学・天然ガス分析）分析、二次元クロマトグラフィーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global 2D chromatography market is projected to reach USD 42.4 million by 2023 from an estimated USD 29.6 million in 2018, at a CAGR of 7.5% during the forecast period. The growth of this market is majorly driven by factors such as initiatives to reduce environmental pollution, R&D investments by pharma companies, government support, and the growing petroleum industry. The 2D chromatography market is segmented on the basis of product, application, and region. Based on type, the market is segmented into 2D gas chromatography and 2D liquid chromatography. In 2018, the 2D gas chromatography segment is expected to account...
  • 脱塩およびバッファー交換の世界市場予測（～2023年）
    MAM-BT-6670 / MarketsandMarkets / 2018年10月10日 / MarketsandMarketsが発行した当調査レポートでは、脱塩およびバッファー交換の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（キット、カセット・カートリッジ、スピンカラム）分析、技法別（サイズ排除クロマトグラフィ、ろ過、透析）分析、用途別（バイオプロセス）分析、脱塩およびバッファー交換の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global desalting and buffer exchange market is projected to reach USD 1,094.8 million in 2023 from USD 679.8 million in 2018, at a CAGR of 10.0%. Desalting is a separation process that removes soluble low molecular weight substances, which have adverse effect on protein function or stability or interfere with downstream applications, from protein and nucleic acid samples. Size exclusion chromatography (gel filtration), ultrafiltration, and dialysis are major techniques used for desalting and buffer exchange. Growth in this market will largely be driven by increasing demand for mAbs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, and growing focus...
  • 神経科学用抗体＆アッセイの世界市場予測（～2023年）
    BT6283 / MarketsandMarkets / 2018年5月16日 / MarketsandMarketsが発行した当調査レポートでは、神経科学用抗体＆アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、装置）別分析、技術別分析、用途別分析、需要先別分析、神経科学用抗体＆アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. This report segments the neuroscience antibodies and assays market into product, technology, application, end user, and region. Based on product, the neuroscience antibodies and assays market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to...
  • 動物向け疼痛治療の世界市場予測（～2023年）
    MD6197 / MarketsandMarkets / 2018年4月20日 / 当調査レポートでは、動物向け疼痛治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（薬剤、デバイス）別分析、用途別分析、動物種類別分析、販売チャネル別分析、動物向け疼痛治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global veterinary pain management market projected to grow at a CAGR of 8.0%”The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market...
  • 疎水性相互作用クロマトグラフィーの世界市場予測（～2023年）
    BT-6542 / MarketsandMarkets / 2018年8月20日 / MarketsandMarketsが発行した当調査レポートでは、疎水性相互作用クロマトグラフィーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス別（樹脂、カラム、バッファー）分析、サンプル別（モノクローナル抗体、ワクチン）分析、エンドユーザー別（製薬会社、CRO・CMO、研究機関）分析、疎水性相互作用クロマトグラフィーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global hydrophobic interaction chromatography market is projected to reach USD 418.2 million in 2023 from USD 291.3 million in 2018, at a CAGR of 7.5%. The increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals are driving the growth of the market. In this report, the market has been categorized based on product & service, sample type, end user, and region. The HIC products market includes resins, columns, buffers, and other HIC products. In 2018, HIC resins are expected to dominate the products market. This segment is also estimated to grow at the highest CAGR during the...
  • 細胞培養の世界市場予測（～2023年）：消耗品、装置、用途、地域別分析
    MAM-BT-2561 / MarketsandMarkets / 2018年4月13日 / MarketsandMarketsが発行した当調査レポートでは、細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、消耗品別分析、装置別分析、用途別分析、地域別分析、細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell culture market is expected to reach USD 26.28 Billion by 2023 from USD 15.32 Billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. This report segments the global market into product, application, end user, and region. Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆